Correlation Analysis
Kenvue Inc. vs Eli Lilly & Co.
KVUE vs LLY
-0.570
Moderate inverse
When one moves up, the other tends to move down.
Kenvue Inc.
↗KVUE
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced November 2025 that it signed a deal to be fully acquired by Kimberly-Clark with the deal expected to close during the second half of 2026.
Market cap 33.2B · 22,000 employees
Eli Lilly & Co.
↗LLY
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Market cap 828.2B · 50,000 employees
Time Series
Relative Performance
Who Moves First
KVUE leads LLY by 6 days
KVUE tends to move before LLY.
After testing 13 timing shifts, the strongest relationship was -0.605 (they moved in opposite directions).
Do They Crash Together?
Correlation by Market Regime
How these series behave when markets are rising, falling, or diverging. A correlation that holds in drawdowns is very different from one that only works in rallies.
Both Rising
+0.684
9 periods · Return correlation when both series rose
Both Falling
-0.675
10 periods · Return correlation when both series fell
Diverging
-0.688
16 periods · Return correlation when series moved apart
R-Squared
32.4%
Share of variance in one series explained by the other.
Trend Agreement
52.2%
How often both series moved in the same direction period-to-period.
Overlap Quality
733
Robust shared window — 733 usable pairs.
Significance
p < 0.001
95% CI: [-0.617, -0.519]
Scatter
XY Regression
Pipeline
Data quality details
Pipeline
Data quality details
Pipeline Summary
733 paired data points survived the daily window.
Raw input
733
1,254
Normalized
733
1,254
Prepared
733
1,254
Aligned
733
733
Invalid removed
0
A: 0 / B: 0
Duplicates removed
0
A: 0 / B: 0
Alignment drops
521
A: 0 / B: 521
Series A
Kenvue Inc.
KVUE
Market cap 33.2B · 22,000 employees
Stock · 733 raw → 733 prepared
Series B
Eli Lilly & Co.
LLY
Market cap 828.2B · 50,000 employees
Stock · 1,254 raw → 1,254 prepared
Sign agreement
100.0%
How often both values share the same sign.
Zero crossings
37
Estimated crossover points between normalized spreads.
Slope
-36.1193
Linear regression slope.
Intercept
1520.2824
Linear regression intercept.
Related Extremes
Highest and Lowest Correlated
Saved 6 hours ago · ID: stock-kvue-vs-stock-lly-daily